Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)

[1]  J. Drijfhout,et al.  An MVA-based Vaccine Targeting the Oncofetal Antigen 5T4 in Patients Undergoing Surgical Resection of Colorectal Cancer Liver Metastases , 2008, Journal of immunotherapy.

[2]  R. Amato,et al.  Vaccination of Prostate Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax): A Phase 2 Trial , 2008, Journal of immunotherapy.

[3]  M. Carroll,et al.  Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses , 2008, Cancer Immunology, Immunotherapy.

[4]  M. Koch,et al.  Detection and Functional Analysis of Tumor Infiltrating T-Lymphocytes (TIL) in Liver Metastases from Colorectal Cancer , 2008, Annals of Surgical Oncology.

[5]  J. Drijfhout,et al.  CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells , 2008, Cancer Immunology, Immunotherapy.

[6]  S. H. van der Burg,et al.  Tumor-specific regulatory T cells in cancer patients. , 2008, Human immunology.

[7]  P. Stern,et al.  Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy , 2008, Expert opinion on biological therapy.

[8]  P. Stern,et al.  Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. , 2007, Cancer research.

[9]  N. Habib,et al.  Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Chemotherapy Induces Potent Immune Responses , 2007, Clinical Cancer Research.

[10]  P. Stern,et al.  E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells. , 2007, Molecular biology of the cell.

[11]  P. Stern,et al.  Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival , 2007, Cancer Immunology, Immunotherapy.

[12]  E. Thiel,et al.  Journal of Translational Medicine in Situ Analysis of Foxp3+ Regulatory T Cells in Human Colorectal Cancer , 2006 .

[13]  M. Carroll,et al.  Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial , 2006, Clinical Cancer Research.

[14]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[15]  Megan Sykes,et al.  Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. Stern,et al.  The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotency , 2003, Journal of Cell Science.

[17]  J. Hjelmborg,et al.  Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells , 2003, Cancer Immunology, Immunotherapy.

[18]  N. Restifo,et al.  Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.

[19]  P. Stern,et al.  Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4. , 2000, Biochimica et biophysica acta.

[20]  J. Shimizu,et al.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. , 1999, Journal of immunology.

[21]  H Nagura,et al.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.

[22]  C. Meijer,et al.  Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  P. Stern,et al.  Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. , 1997, Immunology today.

[24]  P. Stern,et al.  Metastasis‐associated 5T4 antigen disrupts cell‐cell contacts and induces cellular motility in epithelial cells , 1996, International journal of cancer.

[25]  P. Stern,et al.  Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. , 1995, Journal of cell science.

[26]  P. Stern,et al.  Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. , 1994, British Journal of Cancer.

[27]  P. Stern,et al.  The expression of 5T4 antigen in colorectal and gastric carcinoma. , 1992, British Journal of Cancer.

[28]  P. Stern,et al.  Immunohistological distribution of 5T4 antigen in normal and malignant tissues. , 1990, British Journal of Cancer.

[29]  P. Stern,et al.  Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma. , 2008, Cancer immunology, immunotherapy : CII.

[30]  Ekaterina S Jordanova,et al.  High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. , 2007, Cancer research.

[31]  E. Elkord.  Immunology and immunotherapy approaches for prostate cancer , 2007, Prostate Cancer and Prostatic Diseases.